OLAPARIB, BEVACIZUMAB
ESR-20-21103
Phase 2 small_molecule active
Quick answer
OLAPARIB, BEVACIZUMAB for Advanced FIGO Stage III‐IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Advanced FIGO Stage III‐IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active